Table 3. Risk of all-cause mortality associated with PAD.
Unadjusted | Model 1 | Model 2 | Model 3 | |||||
---|---|---|---|---|---|---|---|---|
HR (95% CI) | p-value | HR (95% CI) | p-value | HR (95% CI) | p-value | HR (95% CI) | p-value | |
Subjects without CVD (n=6385) | 4.39 (3.1-6.2) | <0.0001 | 1.93 (1.3-2.8) | 0.001 | 1.59 (1.1-2.4) | 0.02 | 1.39 (0.9-2.2) | 0.1 |
All subjects (n=7458) | 5.28 (4.3-6.5) | <0.0001 | 2.36 (1.9-2.9) | <0.0001 | 1.9 (1.5-2.4) | <0.0001 | 1.78 (1.4-2.3) | 0.0001 |
Model 1 = Adjusted for age, gender, race/ethnicity
Model 2 = Model 1 + atherosclerotic risk factors (diabetes, hypertension, hyperlipidemia, smoking, and chronic kidney disease)
Model 3 = Model 2 + health insurance status, education level, and socioeconomic status (based on poverty-income ratio)